. Author manuscript; available in PMC: 2011 Mar 1.

Published in final edited form as: J Heart Lung Transplant. 2010 Jun 8;29(9):1009–1013. doi: 10.1016/j.healun.2010.04.018

Table 1.

Baseline subject characteristics, laboratory features, and immunosuppressive regimen

Characteristic	Standard (1mg/kg) enoxaparin dose n = 18	Non-standard (0.8mg/kg) enoxaparin dose n = 8	p-value for comparison
Age (years)	57.7 (11.2)	51.4 (10.2)	0.19
Sex (female)	6 (24)	3 (38)	0.46
Body mass index (kg/m²)	26.7 (5.5)	26.4 (3.9)	0.91
Serum creatinine (mg/dL)	1.01 (0.33)	1.23 (0.51)	0.20
Creatinine clearance (ml/min)	88.3 (26.1)	90.9 (16.2)	0.80
Prothrombin time (seconds)	14.1 (1.2)	18.5 (8.3)	0.03*
Partial thromboplastin time (seconds)	33.8 (14.1)	30.7 (5.9)	0.61
AST (IU/L)	27.5 (22.3)	28.9 (14.6)	0.87
ALT (IU/L)	32.0 (19.6)	31.6 (23.3)	0.97
Serum tacrolimus level (mg/L)	8.9 (2.9)	9.5 (4.1)	0.67
Immunosuppressive Regimen
Tacrolimus	18 (100)	6 (88)	0.13
Mycophenolate mofetil	15 (83)	6 (75)	0.62
Prednisone	18 (100)	8 (100)	N/A
Voriconazole	14 (78)	6 (75)	0.88

Format is n (%) for categorical variables or mean (sd) for continuous variables